Dr. Soliman Abdul Kader Fakeeh Hospital Receivables

As of the most recent data (June 2026), 4017.SR shows a receivables of $1.1B. That compares with $1.3B in the prior-year period — down 14.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4017.SR's receivables is now $1.1B (was $1.3B) — a 14.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dr. Soliman Abdul Kader Fakeeh Hospital is outperforming or lagging.

Tracking 4017.SR's receivables over time shows whether Dr. Soliman Abdul Kader Fakeeh Hospital is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1B That compares with $1.3B in the prior-year period — down 14.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Dr. Soliman Abdul Kader Fakeeh Hospital's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.1B) with ownership activity and broader fundamentals.